Urinary complications are common following renal transplantation. The aim of this study is to evaluate the risk factors associated with renal transplant urinary complications. We collected data on 1698 consecutive renal transplants patients. The association of donor, transplant and recipient characteristics with urinary complications was assessed by univariable and multivariable Cox proportional hazards models, fitted to analyze time-to-event outcomes of urinary complications and graft failure. Urinary complications were observed in 105 (6.2%) recipients, with a 2.8% ureteral stricture rate, a 1.7% rate of leak and stricture, and a 1.6% rate of urine leaks. Seventy percent of these complications were definitively managed with a percutaneous intervention. Independent risk factors for a urinary complication included: male recipient, African American recipient, and the "U"-stitch technique. Ureteral stricture was an independent risk factor for graft loss, while urinary leak was not. Laparoscopic donor technique (compared to open living donor nephrectomy) was not associated with more urinary complications. Our data suggest that several patient characteristics are associated with an increased risk of a urinary complication. The U-stitch technique should not be used for the ureteral anastomosis.
Introduction
It is well established that urinary complications are associated with significant morbidity following the kidney transplant operation (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) . The literature on urinary complications following kidney transplant is limited to numerous, relatively small single center experiences and these studies are too small to provide risk factor analysis for urinary complications. A comprehensive evaluation of posttransplant urinary complications, focusing on risk factors, management and the effects on graft function, will enable the clinician to better inform and manage patients.
In this series, we review our experience with urinary complications in renal transplantation. We report 105 urinary complications in 1698 consecutive renal transplants. This large number of cases allows us to complete a multivariable analysis to assess the risk factors for urinary complications in various subgroups of patients. In addition, we assess the effects of urinary complications on graft function. Based on our findings, we conclude with clinical recommendations and suggestions for addition study regarding urinary complications.
Materials and Methods

Patient data
Electronic medical records for all recipients of renal transplants performed consecutively between 7/1/1995 and 7/1/2004 (n = 1698) at the University of Michigan Health System were retrospectively evaluated. Patients who received simultaneous kidney-pancreas, kidney-liver, kidney-heart transplants, or did not have a ureteral anastomosis to the bladder were excluded. Data regarding donor, transplant, surgeon (n = 9), and recipient characteristics as well as graft and patient outcomes were obtained from both a prospectively collected database and review of the electronic medical record and from a dataset provided by the Scientific Registry of Transplant Recipients, based on data submitted by our center to the Organ Procurement and Transplantation Network. Urinary complications were identified by review of radiographic, laboratory and operative records. All bladder anastomoses were completed as a Lich-Gregoir (external ureteroneocystostomy) or using the single U-stitch technique (utilized by a single surgeon) Briefly, the Lich-Gregoir is a continuous suture around the spatulated circumference of the ureter and cystotomy mucosal layer, with closure of the bladder muscle layer over the anastomosis to prevent reflux (14) . The U-stitch technique entails tacking the hood of the ureter to the inside wall of the bladder with a single "U" stitch. The myotomy is then closed over the ureter creating an antirefluxing tunnel (15) (16) (17) . Data on operatively placed stents were available from 1/1/2001 to 7/1/2004. Internal double-J ureteral stents were selectively placed per surgeon preference and transurethral catheters were left in place for 48 h. Patients were managed with three agent maintenance immunosuppression in the immediate postoperative period (cyclosporine, corticosteroids and an antimetabolite). Sirolimus was not used for initial immunosuppression. Immunologically high risk recipients (PRA > 30, African American, or previous transplant) received polyclonal antithymocyte globulin.
Risk Factors for Urinary Complications
Risk factors
Risk factors evaluated as possible predictors of urinary complications included era of transplant, sex, age, race, comorbidities, etiology of renal failure, history of previous renal transplant, donor characteristics, ureteroneocystostomy technique, surgeon, rejection and ischemia times. Expanded criteria donor (ECD) were classified according to Port et al. and included all donors greater than or equal to 60 years of age, plus those donors between 50 and 59 years with at least two of the following three factors: serum creatinine greater than 1.5 mg/dL, cerebrovascular accident as cause of death, and history of hypertension (18) . Data regarding rejection episodes were limited to the first post-operative year.
Definition of urinary complication
For the purposes of this study, urinary complications were defined as symptomatic urinary leak or ureteral stricture requiring intervention. In the Cox model for graft failure, patients with both a urinary leak and stricture were categorized as having a urinary leak.
Human subjects protection
The study was approved by the University of Michigan Institutional Review Board prior to data collection and analysis.
Statistical analysis
The association of donor, transplant and recipient characteristics with urinary complications was assessed by univariable and multivariable Cox proportional hazards models, fitted to analyze time-to-event outcomes of urinary complications and graft failure. All statistical analyses were performed using SAS version 9.1.
Results
Patient characteristics
The baseline characteristics of the study population (1698 consecutive renal transplants) are detailed in Table 1 . The mean posttransplant follow-up was 1446 ± 962 days. Male recipients predominated (58%), and 79% of recipients were white. Diabetes was the most common etiology of renal failure in the study group. Fifty-six percent of the kidneys were from living donors and approximately 40% of the living donor transplants were procured via a laparoscopic approach.
Urinary complication incidence and management
There were 105 (6.2%) urinary complications observed during follow-up (Table 2 ). Two complications were from blood clots after biopsy and one was from a stone (excluded from analysis). The overall urinary complication rates for living donor and deceased donor transplants were 5.7% and 7.8%, respectively.
Isolated ureteral stricture without leak occurred in 47 cases (2.8%) and was the most common urinary complication, representing 44.7% of all urinary complications. More than two-thirds (68.1%) of strictures were managed nonoperatively with a percutaneously placed nephroureteral stent with or without balloon ureteroplasty. The remaining 15 patients required operative reconstruction. Ureteral stricture with associated urine leak occurred in 28 cases (1.7%), representing 26.7% of urinary complications. Of these, 21 (75.0%) were managed with a percutaneous nephrostomy tube or nephroureteral stent, with or without balloon ureteroplasty, while the remainder (n = 7) required an operative reconstruction.
Urine leaks occurred in 27 cases (1.6%) and represented 25.7% of the ureteral complications. Three patients with obvious urine leaks in the immediate postoperative period were taken directly to the operating room. The remainder of the patients had initial placement of a percutaneous nephroureteral stent. If an internal stent had been placed at the time of the operation, it was removed at the time of the nephroureteral stent placement. Eighteen (66.6%) of the urine leaks were ultimately managed either with a Englesbe et al. percutaneous nephrostomy tube with nephroureteral stent while the remainder of the urine leaks required an operative reconstruction.
All of the urine leaks, with or without strictures, presented within 100 days of the renal transplant (median time from renal transplant to presentation with a urine leak was 11.5 days (interquartile range [IQR] 8, 24.5)). Interestingly, 16 (34.0 %) of the ureteral strictures without leaks presented greater than 100 days following the transplant (median time from renal transplant to presentation with a stricture was 19 days (IQR 8,69)).
Overall, 73 (69.5%) of the urinary complications were managed percutaneously without operative reconstruction.
Risk factors for urinary complications
Factors significantly associated with urinary complication in univariable analysis included U-stitch technique, male recipient, African American recipient, ECD kidney, and laparoscopic donor nephrectomy (compared to deceased donor renal transplants). (Table 3 ) Urinary complications were not associated with previous transplant, warm ischemia time, cold ischemia time, surgeon identifier, total ischemia time, donor or recipient body mass index (BMI), episode of acute rejection or donor or recipient age.
A multivariable Cox proportional hazards regression model (adjusted for U-stitch, recipient sex, recipient race, recipient diabetes and technique of organ procurement (laparoscopic living donor nephrectomy, open living donor nephrectomy or deceased donor) was fitted to define independent risk factors for a urinary complication (Table 4) . We found that U-stitch technique, male recipients, and African American recipients were all associated with a higher risk of a urinary complication.
Placement of an intraoperative ureteral stent was commonly done (30.4% of all transplants done between 1/1/2001 and 7/1/2004 (n = 681). Of patients who did not have a stent placed, 5.7% had urinary complications, compared to 4.3% in patients who had a stent placed at the time of transplant. This difference was not statistically significant. Patients with an internal stent and complications presented with urinary leaks. The complication rate directly related to the stent was difficult to assess, but obstruction thought related to the stent occurred in only one patient and the stent was removed earlier than initially planned (6-8 weeks) in 1.8% of patients due to persistent urinary tract infections.
A multivariable Cox proportional hazards regression model (adjusted for year of transplant, ureteral stricture, ureteral leak, recipient diabetes, recipient race, recipient sex and technique of organ procurement) was completed to identify independent risk factors for graft loss. This model noted that ureteral stricture (but not ureteral leak), recipient diabetes, African American recipient, and deceased donor nephrectomy (compared to laparoscopic living donor nephrectomy and open living donor nephrectomy) were all independently associated with graft loss (Table 5 ). 
Discussion
We have shown that recipient factors of male sex, African American race and the U-stitch anastomotic technique, are each significant and independent risk factors for urinary complications after renal transplantation. These findings may be useful to better inform patients about the risks of complications and to assist surgeons in making decisions about management of the urinary reconstruction.
Some interesting insights into the pathophysiology of urinary complications can be gained from our results. Urine leak is presumably related to technical issues (either with the donor operation or the transplant itself) and, as expected, presented early. Conversely, one-third of isolated strictures presented late (more than 100 days posttransplant). These strictures frequently involved a long segment of the donor ureter and were often located proximal to the bladder anastomosis. In addition, ureteral stricture is a significant risk factor for graft loss, while urinary leak is not. Even though late strictures may be related to ischemia or rejection (11, 19) , patients with late strictures in our study did not have seem to have more early rejection (data not shown). The correlation between graft loss and ureteral stricture may be related to rejection and further study is needed to define this relationship. Nonetheless, these data suggest that urinary leaks and strictures can represent different pathophysiologic processes and should be separated in future analyses.
Risk Factors for Urinary Complications
Among the most interesting findings in the risk factor models are that male and African American recipients had significantly more urinary complications than female and nonAfrican American recipients, respectively (Figure 1 ). Thus, African American males were almost four times more likely to have a urinary complication compared to non-African American females. It is possible that the anastomosis is technically more difficult in males related to a deeper, narrower pelvis. Along similar lines, one might posit that BMI would be an independent risk factor for urinary complications (higher BMI being associated with a technically more difficult operation), but this has not been the case in either our study or the reported experience from other groups (20, 21) . There are likely many complex urodynamic fac- tors (such as bladder size and function, urinary outflow obstruction, length of time anuric prior to transplant) and other clinical factors which predispose male and/or African American recipients to urinary complications, and further study is warranted. There is a modest amount of data reporting more urinary complications in pediatric boys compared to girls (8) . It is notable that we did not assess induction therapy as a potential risk factor for a urinary complication, and this may affect African American being a truly independent risk factor for urinary complications. African American recipients received polyclonal antithymocyte induction at the time of transplant, compared to only a small subset of nonAfrican Americans. Further study is needed to determine if antibody induction therapy influences urinary complication rates.
The U-stitch anastomotic technique, which was associated with significant risk, has not been utilized at our center for a number of years, and we recommend against its use.
Like many centers, we now use laparoscopic (handassisted) donor nephrectomy to procure approximately 95% of living donor kidneys. Contrary to other published reports (22) (23) (24) , laparoscopic donor nephrectomy was not associated with more urinary complications, even when controlled for the year of transplant. Actually, compared to open living donor nephrectomy, there was a trend towards fewer complications. This finding could be related to meticulous attention to preservation of periureteral tissue. In our group's experience, it is easier to preserve periureteral tissue when the operative field is under laparoscopic magnification.
For many years, we have utilized a mainly nonoperative approach to the management of leaks and strictures, employing percutaneous nephrostomy tube drainage and conversion to a universal stent with balloon ureteroplasty as needed. Our results support this practice, as the majority of patients can be successfully managed without the need for a secondary operation. Further study is needed to characterize those patients who fail percutaneous management of their urinary complication. Identification of risk factors for failure of the percutaneous approach would reduce the incidence of prolonged and ultimately unsuccessful nonoperative management. The observation that urinary leaks were not associated with graft loss is reassuring both to caregivers and to patients who experience a leak and require a nephrostomy tube in the months following a kidney transplant.
There are multiple case series and five randomized trials indicating that ureteral stents reduce urinary complication rates with minimal risk of stent-related complications (2, 4-6, 9, 10) . Considering the selection bias related to decision to place an intraoperative stent, it is not possible to compare rates of ureteral complications between the stented and nonstented patients in our cohort. In addition, the study was not designed to inform decision making regarding stenting practices.
It is important to point out the limitations of this study. Its design as a retrospective, single center cohort analysis hampers our ability to ascribe direct causality to any of the significant risk factors we have identified. In addition, despite the identification of multiple independent risk factors for urinary complications, the mediation of their effects may be complex, unexplored interactions among the factors may exist, and additional confounders may remain unmeasured and therefore uncharacterized.
In summary, our series has noted several significant risk factors for ureteral complications. We conclude that the Ustitch technique should not be used for the ureteral anastomosis. This comprehensive evaluation of posttransplant urinary complications, focusing on risk factors, management, and the effects on subsequent graft failure, should enable clinicians to better inform and manage patients. Further study is needed to attribute causality of these risk factors to higher rates of urinary complications.
